羅曼股份(605289.SH):上海霍洛維茲對公司整體經營業績影響較小
格隆匯6月11日丨羅曼股份(605289.SH)披露澄清説明公吿,截至2023年3月31日,上海霍洛維茲員工總數24人。主營業務為數字科技領域內的技術服務。主要項目有:北京天文館4D影院、克拉瑪依科技館4D影院及球幕影院、鹽城黃海濕地博物館及主題樂園等。主要客户為政府部門或其投資主體等,暫未廣泛商用。2022年度上海霍洛維茲實現收入1,525.52萬元,僅佔公司2022年度營業收入的4.88%,佔比較低,整體業務規模較小,對公司整體經營業績影響較小。上證E互動回覆中提及的“空間計算技術”與市場熱點在應用場景、應用領域存在一定差異。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.